Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831

Plain-language summary

This study examined tissue samples, using diagnostic laboratory biomarker analysis, from breast cancer patients previously treated on the NCCTG-N9831 clinical trial. It included women with HER-2 positive breast cancer who had suitable tissue samples available. Run by the Alliance for Clinical Trials in Oncology, it was a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Alliance for Clinical Trials in Oncology

Intervention

diagnostic laboratory biomarker analysis

Start date

5/1/2000

Estimated completion

4/1/2019

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria

* Diagnosed with breast cancer and treated on clinical trial NCCTG-N9831

  \* Randomized to treatment
* HER-2 positive disease
* Whole tissue blocks and/or tissue microarray sections available
* Hormone receptor status:

  \* ER/PR status known
* Any menopausal status